About the speaker: Philip Coetzee is the Director of Contract Manufacturing Organization (CMO) Management at Daiichi Sankyo Europe GmbH, based in the Munich Metropolitan Region since May 2020. With over eight years at Catalent Pharma Solutions, Coetzee honed his expertise, notably as a Senior Technical Proposal Lead, where he addressed customer requests for quotations (RFQs) and devised tailored solutions for the manufacture and packaging of medications for the global market. His role involved new product implementation, support to R&D Project Managers, and project management for new product introductions (NPIs), where he also provided technical support to customers. His tenure at Catalent included managing the Corby Recovery Project, where he achieved a record time in transferring products from a burnt facility in England to Germany

About the company: Daiichi Sankyo Europe GmbH, with its production sites in Pfaffenhofen, Germany, and Altkirch, France, is a notable entity in pharmaceutical manufacturing and development. The German site is a hub for both manufacturing, contributing significantly to the company’s global production with over two billion tablets per year, and pharmaceutical development, leading numerous galenic research projects. These sites are integral in developing and producing medications, including active pharmaceutical ingredients and tablet forms, aligning with clinical demands and regulatory standards, and are essential in Daiichi Sankyo’s efforts to provide high-quality pharmaceutical products worldwide

Number of Employees: 17,000

Revenue: 8.83 billion USD